{"data":{"issuanceinfo":{"industrycode":"210002","industry":"軟件服務","ipoprice":{"ceiling":"26.300","floor":"23.500"},"ipodate":{"start":"2020-12-31 00:00:00","end":"2021-01-07 00:00:00"},"minimumcapital":"2656.50","subscribed":"1633.84","marketcap":"237.16億","H_marketcap":"--","pe":"--","codesrate":"20.00","link":"https://staticpdf.iqdii.com/stockdata/notice/02158/2020/2020123100120_c.pdf","ipopricing":"26.300","resultdate":"2021-01-14 00:00:00","enddate":"2021-01-07 00:00:00","listeddate":"2021-01-15 00:00:00","issuenumber":"15645.00萬","issuenumberhK":"7822.50萬","issuenumberother":"7822.50萬","grayprice":"58.25","sponsors":"高盛(亞洲)有限責任公司,中國國際金融香港證券有限公司","raisemoney":"390200.00萬","use":"1、約35%（約1,488.4百萬港元）用于持續加強我們的核心能力，包括數據處理技術和機器學習算法，并提升我們提供客戶所需解決方案的能力；\n2、約35%（約1,488.4百萬港元）用于為業務運營提供資金及進一步進行業務擴張，包括為現有及新市場開發新的應用和解決方案以及在現有或新市 場中銷售及營銷該等新應用程序及解決方案；\n3、約20%（約850.5百萬港元）用于通過戰略合伙、投資和收購來進一步豐富我們的生態系統；\n4、約10%（約425.3百萬港元）用作營運資金及一般企業用途。","shares":100,"leadagent":"高盛(亞洲)有限責任公司,中國國際金融香港證券有限公司,花旗環球金融亞洲有限公司,招商證券(香港)有限公司","bookrunners":"高盛(亞洲)有限責任公司,中國國際金融香港證券有限公司,花旗環球金融亞洲有限公司","coordinator":"高盛(亞洲)有限責任公司,中國國際金融香港證券有限公司,花旗環球金融亞洲有限公司","firstDayOpen":"58.25","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"高盛(亞洲)有限責任公司","code":"E02158","name":"醫渡科技","fullname":"醫渡科技有限公司"},"institutioninfo":{"principaloffice":"中國北京海淀區花園北路9號樓健康智谷大廈8層","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"宮盈盈","secretary":"白蕊,李菁怡","telephone":"","substantialshareholders":"Sweet Panda Limited(44.23%),Sunshine Longevity Limited(10.65%)","principalactivities":"公司提供基于大數據和人工智能(AI)技術的醫療解決方案。","website":"www.yidutechgroup.com"},"managerinfo":[{"managername":"宮盈盈","post":"董事長、首席執行官兼執行董事","rankno":1},{"managername":"楊晶","post":"總裁兼執行董事","rankno":2},{"managername":"閆峻","post":"首席技術官兼執行董事","rankno":3}],"investorinfo":[{"institutionname":"OrbiMed Funds","shareholding":"11,787,900.0","percentage":7.53,"ReleaseDate":"2021-07-15 00:00:00","relatedparty":"OrbiMed Capital LLC","subsidiary":["OrbiMed Funds","Worldwide Healthcare Trust PLC"],"InverstorType":"基金"},{"institutionname":"Yaqut Sdn Bhd","shareholding":"11,787,900.0","percentage":7.53,"ReleaseDate":"2021-07-15 00:00:00","relatedparty":"文萊投資局","subsidiary":["Yaqut Sdn Bhd"],"InverstorType":"公司"},{"institutionname":"加拿大退休金計劃投資委員會","shareholding":"11,787,900.0","percentage":7.53,"ReleaseDate":"2021-07-15 00:00:00","relatedparty":"加拿大養老基金投資公司","subsidiary":["加拿大退休金計劃投資委員會"],"InverstorType":"基金"},{"institutionname":"Matthews Asia Funds","shareholding":"5,893,900.0","percentage":3.77,"ReleaseDate":"2021-07-15 00:00:00","relatedparty":"Matthews International Capital Management, LLC","subsidiary":["Matthews Asia Funds","銘基基金"],"InverstorType":"基金"}],"TotalShareholdingPercentage":39.55},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":9}